Single award · contract
Chimerix Inc: Ar&d for Smallpox Antiviral
Award ID: 75A50122C00047
FY2022 · complete year · data as of 2026-07-11
A single federal award, with both ends of the trail linked.
$213.8M
Total award value
Award 75A50122C00047 is a contract from the Department of Health and Human Services, $213.8M obligated, FY2022 to FY2029, for Chimerix Inc: Ar&d for Smallpox Antiviral. The work is performed in North Carolina. It is classified as NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC AJ15 (General Science & Technology R&D Svcs; General Science & Technology; R&D Facilities & Maj Equip). Source
Award details
Award typeContract
PIID75A50122C00047
Action date2022
Period73 mo
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceNorth Carolina →
CategoryNAICS 541714PSC AJ15
Competed?Not recordedSource
Total (exact)$213,770,068
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.